Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression
Authors
Keywords
-
Journal
NUCLEIC ACIDS RESEARCH
Volume 45, Issue 13, Pages 7897-7908
Publisher
Oxford University Press (OUP)
Online
2017-05-25
DOI
10.1093/nar/gkx490
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
- (2017) Alex Mas Monteys et al. MOLECULAR THERAPY
- Cas-analyzer: an online tool for assessing genome editing results using NGS data
- (2016) Jeongbin Park et al. BIOINFORMATICS
- Therapeutic applications of CRISPR RNA-guided genome editing
- (2016) Taeyoung Koo et al. Briefings in Functional Genomics
- Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma
- (2016) Tang Liu et al. CANCER LETTERS
- SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line
- (2016) Wen Feng et al. GENE
- Antitumor effect and safety profile of systemically delivered oncolytic adenovirus complexed with EGFR-targeted PAMAM-based dendrimer in orthotopic lung tumor model
- (2016) A-Rum Yoon et al. JOURNAL OF CONTROLLED RELEASE
- A multifunctional AAV–CRISPR–Cas9 and its host response
- (2016) Wei Leong Chew et al. NATURE METHODS
- Allele-specific locus binding and genome editing by CRISPR at the p16INK4a locus
- (2016) Toshitsugu Fujita et al. Scientific Reports
- Efficient and Allele-Specific Genome Editing of Disease Loci in Human iPSCs
- (2015) Cory Smith et al. MOLECULAR THERAPY
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts
- (2015) Simona Valletta et al. Oncotarget
- EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
- (2015) Meng-Feng Tsai et al. Scientific Reports
- An Inducible Lentiviral Guide RNA Platform Enables the Identification of Tumor-Essential Genes and Tumor-Promoting Mutations In Vivo
- (2015) Brandon J. Aubrey et al. Cell Reports
- 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
- (2014) B. Besse et al. ANNALS OF ONCOLOGY
- Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing
- (2014) Qiurong Ding et al. CIRCULATION RESEARCH
- Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR/Cas9
- (2014) Ranran Cheng et al. FEBS LETTERS
- Targeting Cdk11 in osteosarcoma cells using the CRISPR-cas9 system
- (2014) Yong Feng et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Establishment and biological characteristics of acquired gefitinib resistance in cell line NCI-H1975/gefinitib-resistant with epidermal growth factor receptor T790M mutation
- (2014) BAO-XIA ZHAO et al. Molecular Medicine Reports
- A guide to genome engineering with programmable nucleases
- (2014) Hyongbum Kim et al. NATURE REVIEWS GENETICS
- Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells
- (2014) Yuchen Liu et al. Nature Communications
- AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
- (2014) D. A. E. Cross et al. Cancer Discovery
- Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
- (2013) Brenda K. Edwards et al. CANCER
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
- (2013) Haoyi Wang et al. CELL
- Heritable Gene Knockout in Caenorhabditis elegans by Direct Injection of Cas9–sgRNA Ribonucleoproteins
- (2013) Seung Woo Cho et al. GENETICS
- Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases
- (2013) Y. H. Sung et al. GENOME RESEARCH
- Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
- (2013) Seung Woo Cho et al. NATURE BIOTECHNOLOGY
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer
- (2012) Nicola K Green et al. Nanomedicine
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- The use of oncolytic viruses to overcome lung cancer drug resistance
- (2012) Vladimir Beljanski et al. Current Opinion in Virology
- Successful rechallenge with erlotinib in a patient with EGFR-mutant lung adenocarcinoma who developed gefitinib-related interstitial lung disease
- (2009) Tomoya Fukui et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer gene therapy with targeted adenoviruses
- (2008) Houria Bachtarzi et al. Expert Opinion on Drug Delivery
- Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition
- (2008) J Y Yoo et al. GENE THERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started